For COVID-19 vaccine updates, please review our information guide. For patient eligibility and scheduling availability, please visit VaccineTogetherNY.org.

Improved control of tuberculosis and activation of macrophages in mice lacking protein kinase R.

TitleImproved control of tuberculosis and activation of macrophages in mice lacking protein kinase R.
Publication TypeJournal Article
Year of Publication2012
AuthorsWu K, Koo J, Jiang X, Chen R, Cohen SN, Nathan C
JournalPLoS One
Volume7
Issue2
Paginatione30512
Date Published2012
ISSN1932-6203
KeywordsAnimals, Apoptosis, eIF-2 Kinase, Interferon-gamma, Interleukin-10, Macrophage Activation, Mice, Mycobacterium tuberculosis, Protein Kinase Inhibitors, Tuberculosis
Abstract

Host factors that microbial pathogens exploit for their propagation are potential targets for therapeuic countermeasures. No host enzyme has been identified whose genetic absence benefits the intact mammalian host in vivo during infection with Mycobacterium tuberculosis (Mtb), the leading cause of death from bacterial infection. Here, we report that the dsRNA-dependent protein kinase (PKR) is such an enzyme. PKR-deficient mice contained fewer viable Mtb and showed less pulmonary pathology than wild type mice. We identified two potential mechanisms for the protective effect of PKR deficiency: increased apoptosis of macrophages in response to Mtb and enhanced activation of macrophages in response to IFN-gamma. The restraining effect of PKR on macrophage activation was explained by its mediation of a previously unrecognized ability of IFN-gamma to induce low levels of the macrophage deactivating factor interleukin 10 (IL10). These observations suggest that PKR inhibitors may prove useful as an adjunctive treatment for tuberculosis.

DOI10.1371/journal.pone.0030512
Alternate JournalPLoS ONE
PubMed ID22359543
PubMed Central IDPMC3281035

Weill Cornell Medicine Microbiology and Immunology 1300 York Avenue, Box 62 New York, NY 10065 Phone: (212) 746-6505 Fax: (212) 746-8587